Search Results - "Peng, Cheng Yuan"

Editorial: tripartite motif 26 inhibits hepatitis B virus replication and its genetic polymorphism predicts response to interferon treatment—towards a better understanding of interferon responsiveness in chronic hepatitis B by Peng, Cheng‐Yuan

“…LINKED CONTENT This article is linked to Luo et al papers. To view these articles, visit https://doi.org/10.1111/apt.17124 and https://doi.org/10.1111/apt.17181…”
Get full text

Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply by Chen, Chien‐Hung, Peng, Cheng‐Yuan

“…LINKED CONTENT This article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.17602 and…”
Get full text

Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy by Peng, Cheng-Yuan, Chien, Rong-Nan, Liaw, Yun-Fan

“…Summary Following development of liver cirrhosis in patients with chronic hepatitis B, liver disease may continue to progress and decompensation or…”
Get full text

Editorial: identifying candidates for pegylated interferon add‐on to entecavir therapy in patients with HBeAg‐positive chronic hepatitis B by Peng, Cheng‐Yuan

“…Linked ContentThis article is linked to Liem et al and Liem and Janssen papers. To view these articles, visit https://doi.org/10.1111/apt.15098 and…”
Get full text

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B by Hsu, Yao-Chun, Wong, Grace Lai-Hung, Chen, Chien-Hung, Peng, Cheng-Yuan, Yeh, Ming-Lun, Cheung, Ka-Shing, Toyoda, Hidenori, Huang, Chung-Feng, Trinh, Huy, Xie, Qing, Enomoto, Masaru, Liu, Li, Yasuda, Satoshi, Tanaka, Yasuhito, Kozuka, Ritsuzo, Tsai, Pei-Chien, Huang, Yen-Tsung, Wong, Christopher, Huang, Rui, Jang, Tyng-Yuan, Hoang, Joseph, Yang, Hwai-I, Li, Jiayi, Lee, Dong-Hyun, Takahashi, Hirokazu, Zhang, Jian Q., Ogawa, Eiichi, Zhao, Changqing, Liu, Chenghai, Furusyo, Norihiro, Eguchi, Yuichiro, Wong, Clifford, Wu, Chao, Kumada, Takashi, Yuen, Man-Fung, Yu, Ming-Lung, Nguyen, Mindie H.

“…It is unclear whether entecavir (ETV) and tenofovir disoproxil fumarate (TDF) differ in their effectiveness for preventing hepatocellular carcinoma (HCC) in…”
Get full text

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients by Su, Tung-Hung, Hu, Tsung-Hui, Chen, Chi-Yi, Huang, Yi-Hsiang, Chuang, Wan-Long, Lin, Chun-Che, Wang, Chia-Chi, Su, Wei-Wen, Chen, Ming-Yao, Peng, Cheng-Yuan, Chien, Rong-Nan, Huang, Yi-Wen, Wang, Horng-Yuan, Lin, Chih-Lin, Yang, Sheng-Shun, Chen, Tsung-Ming, Mo, Lein-Ray, Hsu, Shih-Jer, Tseng, Kuo-Chih, Hsieh, Tsai-Yuan, Suk, Fat-Moon, Hu, Chi-Tan, Bair, Ming-Jong, Liang, Cheng-Chao, Lei, Yung-Chao, Tseng, Tai-Chung, Chen, Chi-Ling, Kao, Jia-Horng

“…Background & Aims Oral antiviral therapy may reduce the disease progression of chronic hepatitis B (CHB) patients. We aimed to further investigate the efficacy…”
Get full text

Editorial: a baseline tool for predicting response to peginterferon alfa‐2a in HBeAg‐positive patients—same score, different outcomes by Peng, Cheng‐Yuan

“…Linked ContentThis article is linked to Chan et al and Chan papers. To view these articles visit https://doi.org/10.1111/apt.14862 and…”
Get full text

Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized, Controlled Trial by Su, Kuan-Pin, Lai, Hsueh-Chou, Yang, Hui-Ting, Su, Wen-Pang, Peng, Cheng-Yuan, Chang, Jane Pei-Chen, Chang, Hui-Chih, Pariante, Carmine M

“…Background Interferon (IFN)-α therapy for chronic hepatitis C virus infection is frequently associated with depression. The routine prophylaxis with…”
Get full text

Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B by Chen, Chien‐Hung, Peng, Cheng‐Yuan, Hu, Tsung‐Hui, Wang, Jing‐Houng, Hung, Chao‐Hung, Lu, Sheng‐Nan

“…Summary Background/Aims To compare the rates of hepatitis B surface antigen (HBsAg) loss after discontinuation of entecavir versus tenofovir disoproxil…”
Get full text

Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions by Tak, Won Young, Lin, Shi-Ming, Wang, Yijun, Zheng, Jiasheng, Vecchione, Aldo, Park, Soo Young, Chen, Min Hua, Wong, Stephen, Xu, Ruocai, Peng, Cheng-Yuan, Chiou, Yi-You, Huang, Guan-Tarn, Cai, Jianqiang, Abdullah, Basri Johan Jeet, Lee, June Sung, Lee, Jae Young, Choi, Jong-Young, Gopez-Cervantes, Julieta, Sherman, Morris, Finn, Richard S, Omata, Masao, O'Neal, Michael, Makris, Lukas, Borys, Nicholas, Poon, Ronnie, Lencioni, Riccardo

“…Lyso-thermosensitive liposomal doxorubicin (LTLD) consists of doxorubicin contained within a heat-sensitive liposome. When heated to ≥40°C, LTLD locally…”
Get full text

On‐treatment predictors of hepatocellular carcinoma in patients with chronic hepatitis B by Peng, Cheng‐Yuan, Chen, Chien‐Hung

“…We read with interest the article by Ahn et al in Liver International. This study evaluated the predictive performance of various parameters at treatment…”
Get full text

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study by Manns, Michael, Prof, Pol, Stanislas, Prof, Jacobson, Ira M, Prof, Marcellin, Patrick, Prof, Gordon, Stuart C, Prof, Peng, Cheng-Yuan, MD, Chang, Ting-Tsung, Prof, Everson, Gregory T, Prof, Heo, Jeong, Prof, Gerken, Guido, Prof, Yoffe, Boris, Prof, Towner, William J, MD, Bourliere, Marc, MD, Metivier, Sophie, MD, Chu, Chi-Jen, MD, Sievert, William, Prof, Bronowicki, Jean-Pierre, Prof, Thabut, Dominique, Prof, Lee, Youn-Jae, Prof, Kao, Jia-Horng, Prof, McPhee, Fiona, PhD, Kopit, Justin, PhD, Mendez, Patricia, MD, Linaberry, Misti, MPH, Hughes, Eric, MD, Noviello, Stephanie, MD

“…Summary Background An unmet need exists for interferon-free and ribavirin-free treatments for chronic hepatitis C virus (HCV) infection. In this study, we…”
Get full text

Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan by Liu, Chen‐Hua, Yu, Ming‐Lung, Peng, Cheng‐Yuan, Hsieh, Tsai‐Yuan, Huang, Yi‐Hsiang, Su, Wei‐Wen, Cheng, Pin‐Nan, Lin, Chih‐Lin, Lo, Ching‐Chu, Chen, Chi‐Yi, Chen, Jyh‐Jou, Ma, Qian, Brooks‐Rooney, Craig, Kao, Jia‐Horng

“…Summary Background While direct‐acting antivirals have been approved for treating hepatitis C, the guidelines highlight the importance of considering potential…”
Get full text

Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan by Chen, Chi‐Yi, Huang, Chung‐Feng, Cheng, Pin‐Nan, Tseng, Kuo‐Chih, Lo, Ching‐Chu, Kuo, Hsing‐Tao, Huang, Yi‐Hsiang, Tai, Chi‐Ming, Peng, Cheng‐Yuan, Bair, Ming‐Jong, Chen, Chien‐Hung, Yeh, Ming‐Lun, Lin, Chih‐Lang, Lin, Chun‐Yen, Lee, Pei‐Lun, Chong, Lee‐Won, Hung, Chao‐Hung, Huang, Jee‐Fu, Yang, Chi‐Chieh, Hu, Jui‐Ting, Lin, Chih‐Wen, Chen, Chun‐Ting, Wang, Chia‐Chi, Su, Wei‐Wen, Hsieh, Tsai‐Yuan, Lin, Chih‐Lin, Tsai, Wei‐Lun, Lee, Tzong‐Hsi, Chen, Guei‐Ying, Wang, Szu‐Jen, Chang, Chun‐Chao, Mo, Lein‐Ray, Yang, Sheng‐Shun, Wu, Wen‐Chih, Huang, Chia‐Sheng, Hsiung, Chou‐Kwok, Kao, Chien‐Neng, Tsai, Pei‐Chien, Liu, Chen‐Hua, Lee, Mei‐Hsuan, Liu, Chun‐Jen, Dai, Chia‐Yen, Kao, Jia‐Horng, Chuang, Wan‐Long, Lin, Han‐Chieh, Yu, Ming‐Lung

“…Background/aims Direct‐acting antivirals (DAAs) are highly effective in treating chronic hepatitis C virus (HCV)‐infected patients. The real‐world treatment…”
Get full text

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open‐label study by Liaw, Yun‐Fan, Raptopoulou‐Gigi, Maria, Cheinquer, Hugo, Sarin, Shiv Kumar, Tanwandee, Tawesak, Leung, Nancy, Peng, Cheng‐Yuan, Myers, Robert P., Brown, Robert S., Jeffers, Lennox, Tsai, Naoky, Bialkowska, Jolanta, Tang, Shijie, Beebe, Suzanne, Cooney, Elizabeth

“…A randomized, open‐label comparative study of entecavir versus adefovir therapy was performed in subjects with chronic hepatitis B who had hepatic…”
Get full text

Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients by Chen, Chien-Hung, Peng, Cheng-Yuan, Kuo, Yuan-Hung, Hu, Tsung-Hui, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan

“…This study investigated the incidence and predictors of hepatitis B virus (HBV) relapse in patients with hepatitis B e antigen (HBeAg)-positive chronic…”
Get full text

Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents by Hsu, Wei-Fan, Lai, Hsueh-Chou, Su, Wen-Pang, Lin, Chia-Hsin, Chuang, Po-Heng, Chen, Sheng-Hung, Chen, Hung-Yao, Wang, Hung-Wei, Huang, Guan-Tarn, Peng, Cheng-Yuan

“…Studies on temporal changes in noninvasive fibrosis indices and liver stiffness measurement (LSM) in patients with chronic hepatitis C (CHC) treated with…”
Get full text

Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B by Hsu, Yao-Chun, Yeh, Ming-Lun, Wong, Grace Lai-Hung, Chen, Chien-Hung, Peng, Cheng-Yuan, Buti, Maria, Enomoto, Masaru, Xie, Qing, Trinh, Huy, Preda, Carmen, Liu, Li, Cheung, Ka-Shing, Yeo, Yee Hui, Hoang, Joseph, Huang, Chung-Feng, Riveiro-Barciela, Mar, Kozuka, Ritsuzo, Istratescu, Doina, Tsai, Pei-Chien, Accarino, Elena Vargas, Lee, Dong-Hyun, Wu, Jia-Ling, Huang, Jee Fu, Dai, Chia-Yen, Cheung, Ramsey, Chuang, Wan-Long, Yuen, Man-Fung, Wong, Vincent Wai-Sun, Yu, Ming-Lung, Nguyen, Mindie H

“…Abstract Background Long-term incidences and baseline determinants of functional cure (hepatitis B surface antigen [HBsAg] seroclearance) during entecavir…”
Get full text

Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy by Yang, Hwai-I, Yeh, Ming-Lun, Wong, Grace L, Peng, Cheng-Yuan, Chen, Chien-Hung, Trinh, Huy N, Cheung, Ka-Shing, Xie, Qing, Su, Tung-Hung, Kozuka, Ritsuzo, Lee, Dong-Hyun, Ogawa, Eiichi, Zhao, Changqing, Ning, Hui-Bin, Huang, Rui, Li, Jiayi, Zhang, Jian Q, Ide, Tatsuya, Xing, Huichun, Iwane, Shinji, Takahashi, Hirokazu, Wong, Christopher, Wong, Clifford, Lin, Chia-Hsin, Hoang, Joseph, Le, An, Henry, Linda, Toyoda, Hidenori, Ueno, Yoshiyuki, Gane, Edward J, Eguchi, Yuichiro, Kurosaki, Masayuki, Wu, Chao, Liu, Chenghai, Shang, Jia, Furusyo, Norihiro, Enomoto, Masaru, Kao, Jia-Horng, Yuen, Man-Fung, Yu, Ming-Lung, Nguyen, Mindie H

“…Abstract Background Patients on oral antiviral (OAV) therapy remain at hepatocellular carcinoma (HCC) risk. Risk prediction tools distinguishing treated…”
Get full text

Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib by Hsieh, Ming-Han, Kao, Tzu-Yu, Hsieh, Ting-Hui, Kao, Chun-Chi, Peng, Cheng-Yuan, Lai, Hsueh-Chou, Chuang, Po-Heng, Kao, Jung-Ta

“…It remains limited whether diabetes mellitus (DM) and hypertension (HTN) affect the prognosis of advanced hepatocellular carcinoma (HCC) treated with…”
Get full text